First Command Financial Services’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-765
Closed -$7K 378
2019
Q4
$7K Hold
765
﹤0.01% 328
2019
Q3
$5K Hold
765
﹤0.01% 351
2019
Q2
$7K Hold
765
﹤0.01% 350
2019
Q1
$12K Hold
765
0.01% 323
2018
Q4
$12K Hold
765
0.01% 327
2018
Q3
$16K Hold
765
﹤0.01% 314
2018
Q2
$19K Sell
765
-155
-17% -$3.16K ﹤0.01% 303
2018
Q1
$16K Sell
920
-112
-11% -$2.19K ﹤0.01% 317
2017
Q4
$20K Sell
1,032
-605
-37% -$9.1K 0.01% 288
2017
Q3
$29K Sell
1,637
-191
-10% -$4.3K 0.02% 248
2017
Q2
$61K Sell
1,828
-455
-20% -$14.1K 0.04% 174
2017
Q1
$73K Buy
2,283
+560
+33% +$19.1K 0.05% 152
2016
Q4
$62K Buy
+1,723
New +$68.8K 0.05% 173

Other funds holding TEVA

First Command Financial Services's TEVA Position: Q1 2020 in Review

First Command Financial Services sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2020, closing a stake of 765 shares — an estimated $7K sold.

First Command Financial Services first reported a position in TEVA in Q4 2016 and held it in 13 quarters. The position peaked at $73K in Q1 2017. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

  • First Command Financial Services reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2020 after selling out during the quarter.
  • First Command Financial Services sold 765 Teva Pharmaceutical Industries Limited shares in Q1 2020, an estimated $7K.
  • First Command Financial Services first reported a position in Teva Pharmaceutical Industries Limited in Q4 2016 and held it in 13 quarters.
  • First Command Financial Services's Teva Pharmaceutical Industries Limited position peaked at $73K in Q1 2017.
  • 459 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2020.

Based on First Command Financial Services's 13F filing for Q1 2020, filed 20 Apr 2020.